Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goni

Showing results (461-470 of 567) with videos related to

Pageof 57
Sort By:
European Journal of Internal Medicine|March 20, 2026
Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohortJens Vikse, Marco Lanzillotta, Elisabetta Goni, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Somatic and Stem Cell Bank to Study the Contribution of African Ancestry to Dementia: African iPSC InitiativeMahmoud B Maina, Murtala B Isah, Jacob A Marsh, et al.
Contemporary Clinical Trials|September 12, 2018
Evaluating the clinical implementation of structured exercise: A randomized controlled trial among non-insulin dependent type II diabeticsLida Faroqi, Myo Wong, Saniya Bonde, et al.
BMC Rheumatology|June 11, 2020
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapyShubhadeep Sinha, Biswadip Ghosh, Syamasis Bandyopadhyay, et al.
Therapie|February 14, 2015
Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?Pierre Marquet, Pierre-Henry Longeray, Fabrice Barlesi, et al.
Nature Communications|June 4, 2024
An implantable piezoelectric ultrasound stimulator (ImPULS) for deep brain activationJason F Hou, Md Osman Goni Nayeem, Kian A Caplan, et al.
Annals of Hematology|December 8, 2019
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemiaRahul Kaundal, Prateek Bhatia, Arihant Jain, et al.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
Lifestyle Genomics|January 26, 2025
Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR TrialCristina Razquin, Joaquín Fernandez-Irigoyen, María Teresa Barrio-López, et al.
European Journal of Human Genetics : EJHG|February 18, 2016
Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutationsJoshi Stephen, Thierry Vilboux, Yael Haberman, et al.
Pageof 57

Showing results (461-470 of 567) with videos related to

Sort By:
Pageof 57
European Journal of Internal Medicine|March 20, 2026
Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohortJens Vikse, Marco Lanzillotta, Elisabetta Goni, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Somatic and Stem Cell Bank to Study the Contribution of African Ancestry to Dementia: African iPSC InitiativeMahmoud B Maina, Murtala B Isah, Jacob A Marsh, et al.
Contemporary Clinical Trials|September 12, 2018
Evaluating the clinical implementation of structured exercise: A randomized controlled trial among non-insulin dependent type II diabeticsLida Faroqi, Myo Wong, Saniya Bonde, et al.
BMC Rheumatology|June 11, 2020
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapyShubhadeep Sinha, Biswadip Ghosh, Syamasis Bandyopadhyay, et al.
Therapie|February 14, 2015
Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?Pierre Marquet, Pierre-Henry Longeray, Fabrice Barlesi, et al.
Nature Communications|June 4, 2024
An implantable piezoelectric ultrasound stimulator (ImPULS) for deep brain activationJason F Hou, Md Osman Goni Nayeem, Kian A Caplan, et al.
Annals of Hematology|December 8, 2019
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemiaRahul Kaundal, Prateek Bhatia, Arihant Jain, et al.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
Lifestyle Genomics|January 26, 2025
Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR TrialCristina Razquin, Joaquín Fernandez-Irigoyen, María Teresa Barrio-López, et al.
European Journal of Human Genetics : EJHG|February 18, 2016
Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutationsJoshi Stephen, Thierry Vilboux, Yael Haberman, et al.
Pageof 57